-
1
-
-
2642709177
-
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators
-
Palella FJ, Jr., Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998 Mar 26; 338(13):853-60.
-
(1998)
N Engl J Med
, vol.338
, Issue.13
, pp. 853-860
-
-
Palella Jr., F.J.1
Delaney, K.M.2
Moorman, A.C.3
-
2
-
-
3042654825
-
Treatment outcomes afer highly active antiretroviral therapy: A meta-analysis of randomised controlled trials
-
Enanoria WT, Ng C, Saha SR, Colford Jr JM. Treatment outcomes afer highly active antiretroviral therapy: a meta-analysis of randomised controlled trials. Lancet Infect Dis. 2004; 4(7):414-25.
-
(2004)
Lancet Infect Dis
, vol.4
, Issue.7
, pp. 414-425
-
-
Enanoria, W.T.1
Ng, C.2
Saha, S.R.3
Colford Jr., J.M.4
-
3
-
-
0034699898
-
Adverse efects of antiretroviral therapy
-
Carr A, Cooper DA. Adverse efects of antiretroviral therapy. Lancet. 2000; 356(9239):1423-30.
-
(2000)
Lancet
, vol.356
, Issue.9239
, pp. 1423-1430
-
-
Carr, A.1
Cooper, D.A.2
-
4
-
-
33747605338
-
Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy
-
Wohl DA, McComsey G, Tebas P et al. Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. Clin Infect Dis. 2006; 43(5):645-53.
-
(2006)
Clin Infect Dis
, vol.43
, Issue.5
, pp. 645-653
-
-
Wohl, D.A.1
Mccomsey, G.2
Tebas, P.3
-
5
-
-
0142043954
-
Association between protease inhibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus: A systematic review
-
Rhew DC, Bernal M, Aguilar D, Iloeje U, Goetz MB. Association between protease inhibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus: a systematic review. Clin Infect Dis. 2003; 37(7):959-72.
-
(2003)
Clin Infect Dis
, vol.37
, Issue.7
, pp. 959-972
-
-
Rhew, D.C.1
Bernal, M.2
Aguilar, D.3
Iloeje, U.4
Goetz, M.B.5
-
6
-
-
0042768569
-
Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population
-
Saves M, Chene G, Ducimetiere P et al. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis., 2003; 37(2):292-8.
-
(2003)
Clin Infect Dis
, vol.37
, Issue.2
, pp. 292-298
-
-
Saves, M.1
Chene, G.2
Ducimetiere, P.3
-
7
-
-
34247537169
-
Class of antiretroviral drugs and the risk of myocardial infarction
-
Friis-Moller N, Reiss P, Sabin CA et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007; 356(17):1723-35.
-
(2007)
N Engl J Med
, vol.356
, Issue.17
, pp. 1723-1735
-
-
Friis-Moller, N.1
Reiss, P.2
Sabin, C.A.3
-
8
-
-
33744475605
-
Sustainability of Brazilian policy for access to antiretroviral drugs
-
Grangeiro A Teixeira L, Bastos FI, Teixeira P. Sustainability of Brazilian policy for access to antiretroviral drugs. Rev Saude Publica. 2006; 40 Suppl:60-9.
-
(2006)
Rev Saude Publica
, vol.40
, Issue.SUPPL
, pp. 60-69
-
-
Grangeiro, A.1
Teixeira, L.2
Bastos, F.I.3
Teixeira, P.4
-
9
-
-
33744469563
-
AIDS epidemic trends afer the introduction of antiretroviral therapy in Brazil
-
Dourado I, Veras MA, Barreira D, de Brito AM. AIDS epidemic trends afer the introduction of antiretroviral therapy in Brazil. Rev Saude Publica. 2006; 40 Suppl:9-17.
-
(2006)
Rev Saude Publica
, vol.40
, Issue.SUPPL.
, pp. 9-17
-
-
Dourado, I.1
Veras, M.A.2
Barreira, D.3
de Brito, A.M.4
-
10
-
-
0035749781
-
Hyperlipidemia related to the use of HIV-protease inhibitors: Natural history and results of treatment with fenofbrate
-
Caramelli B, de Bernoche CY, Sartori AM et al. Hyperlipidemia related to the use of HIV-protease inhibitors: natural history and results of treatment with fenofbrate. Braz J Infect Dis. 2001; 5(6):332-8.
-
(2001)
Braz J Infect Dis
, vol.5
, Issue.6
, pp. 332-338
-
-
Caramelli, B.1
de Bernoche, C.Y.2
Sartori, A.M.3
-
11
-
-
27344444022
-
High frequency of Fredricksons phenotypes IV and IIb in Brazilians infected by human immunodeficiency virus
-
Albuquerque EM, de Faria EC, Oliveira HC, Magro DO, Castilho LN. High frequency of Fredricksons phenotypes IV and IIb in Brazilians infected by human immunodeficiency virus. BMC Infect Dis. 2005; 5(1):47.
-
(2005)
BMC Infect Dis
, vol.5
, Issue.1
, pp. 47
-
-
Albuquerque, E.M.1
de Faria, E.C.2
Oliveira, H.C.3
Magro, D.O.4
Castilho, L.N.5
-
12
-
-
34248392637
-
Antiretroviral treatment for HIV infection/AIDS and the risk of developing hyperglycemia and hyperlipidemia
-
de Araujo PS, de Alencar Ximenes RA, Lopes CF, Duarte J Y, da Silva MM, Carneiro EM. Antiretroviral treatment for HIV infection/AIDS and the risk of developing hyperglycemia and hyperlipidemia. Rev Inst Med Trop São Paulo. 2007; 49(2):73-8.
-
(2007)
Rev Inst Med Trop São Paulo
, vol.49
, Issue.2
, pp. 73-78
-
-
de Araujo, P.S.1
de Alencar Ximenes, R.A.2
Lopes, C.F.3
Duarte, J.Y.4
da Silva, M.M.5
Carneiro, E.M.6
-
13
-
-
0035524623
-
SBC. III Brazilian Guidelines on Dyslipidemias and Guideline of Atherosclerosis Prevention from Atherosclerosis Department of Sociedade Brasileira de Cardiologia
-
SBC. III Brazilian Guidelines on Dyslipidemias and Guideline of Atherosclerosis Prevention from Atherosclerosis Department of Sociedade Brasileira de Cardiologia. Arq Bras Cardiol. 2001;77 Suppl 3:1-48.
-
(2001)
Arq Bras Cardiol
, vol.77
, Issue.SUPPL. 3
, pp. 1-48
-
-
-
14
-
-
0020663195
-
Summary estimates of cholesterol used to predict coronary heart disease
-
Castelli WP, Abbott RD, McNamara PM. Summary estimates of cholesterol used to predict coronary heart disease. Circulation. 1983; 67(4):730-4.
-
(1983)
Circulation
, vol.67
, Issue.4
, pp. 730-734
-
-
Castelli, W.P.1
Abbott, R.D.2
Mcnamara, P.M.3
-
15
-
-
0042832397
-
Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: Recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group
-
Dube M P, Stein JH, Aberg JA et al. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis. 2003; 37(5):613-27.
-
(2003)
Clin Infect Dis
, vol.37
, Issue.5
, pp. 613-627
-
-
Dube, M.P.1
Stein, J.H.2
Aberg, J.A.3
-
16
-
-
0032510639
-
Prediction of coronary heart disease using risk factor categories
-
Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97(18):1837-47.
-
(1998)
Circulation
, vol.97
, Issue.18
, pp. 1837-1847
-
-
Wilson, P.W.1
D'agostino, R.B.2
Levy, D.3
Belanger, A.M.4
Silbershatz, H.5
Kannel, W.B.6
-
17
-
-
12144286934
-
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: Are different antiretroviral drugs associated with different lipid profiles?
-
Fontas E, van Leth F, Sabin CA et al. Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? J Infect Dis. 2004; 189(6):1056-74.
-
(2004)
J Infect Dis
, vol.189
, Issue.6
, pp. 1056-1074
-
-
Fontas, E.1
van Leth, F.2
Sabin, C.A.3
-
18
-
-
0038386036
-
Cardiovascular disease risk factors in HIV patient - association with antiretroviral therapy. Results from the DAD study
-
Friis-Moller N, Weber R, Reiss P et al. Cardiovascular disease risk factors in HIV patient - association with antiretroviral therapy. Results from the DAD study. Aids. 2003; 17(8):1179-93.
-
(2003)
Aids
, vol.17
, Issue.8
, pp. 1179-1193
-
-
Friis-Moller, N.1
Weber, R.2
Reiss, P.3
-
19
-
-
0034253091
-
Absence of association between individual thymidine analogues or nonnucleoside analogues and lipid abnormalities in HIV-1-infected persons on initial therapy
-
Matthews GV, Moyle GJ, Mandalia S, Bower M, Nelson M, Gazzard BG. Absence of association between individual thymidine analogues or nonnucleoside analogues and lipid abnormalities in HIV-1-infected persons on initial therapy. J Acquir Immune Defc Syndr. 2000; 24(4):310-5.
-
(2000)
J Acquir Immune Defc Syndr
, vol.24
, Issue.4
, pp. 310-315
-
-
Matthews, G.V.1
Moyle, G.J.2
Mandalia, S.3
Bower, M.4
Nelson, M.5
Gazzard, B.G.6
-
20
-
-
0035824764
-
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile
-
van der Valk M, Kastelein JJ, Murphy RL et al. Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile. Aids. 2001; 15(18):2407-14.
-
(2001)
Aids
, vol.15
, Issue.18
, pp. 2407-2414
-
-
van der Valk, M.1
Kastelein, J.J.2
Murphy, R.L.3
|